Provectus Biopharmaceuticals, Inc.
PVCT
$0.05
$0.00-0.75%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 416.70% | -10.90% | 235.07% | -80.56% | -1.15% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.69% | -25.53% | 117.11% | -23.88% | -16.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -32.30% | -24.52% | -19.60% | 160.17% | -58.15% |
| Total Current Assets | 197.33% | -18.93% | 104.28% | -51.08% | -12.50% |
|
|
|||||
| Total Current Assets | 197.33% | -18.93% | 104.28% | -51.08% | -12.50% |
| Net Property, Plant & Equipment | -10.75% | -9.57% | -8.67% | -7.92% | 817.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 155.11% | -17.19% | 66.11% | -41.87% | 8.42% |
|
|
|||||
| Total Accounts Payable | 14.31% | 13.84% | -39.19% | -10.16% | 76.21% |
| Total Accrued Expenses | -10.83% | 12.73% | 11.44% | 7.01% | 17.62% |
| Short-term Debt | -42.72% | -25.94% | 105.67% | 95.03% | -56.42% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.34% | -4.48% | 19.62% | -5.69% | -3.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.43% | 4.99% | 6.58% | -0.33% | 13.22% |
|
|
|||||
| Total Current Liabilities | 6.43% | 4.99% | 6.58% | -0.33% | 13.22% |
| Long-Term Debt | -- | -- | 0.00% | -- | -- |
| Short-term Debt | -42.72% | -25.94% | 105.67% | 95.03% | -56.42% |
| Capital Leases | -19.07% | -15.91% | -13.54% | -11.84% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.19% | 4.40% | 6.27% | -0.15% | 15.03% |
|
|
|||||
| Common Stock & APIC | 0.56% | 0.34% | 0.40% | 0.41% | 0.41% |
| Retained Earnings | -0.37% | -0.49% | -0.45% | -0.50% | -0.70% |
| Treasury Stock & Other | 0.17% | 0.50% | 0.17% | 0.17% | 0.49% |
| Total Common Equity | 6.66% | -6.75% | -2.40% | -4.76% | -15.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.61% | 1.32% | 1.34% | 1.36% | 2.08% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.61% | 1.32% | 1.34% | 1.36% | 2.08% |
|
|
|||||
| Total Common Equity | 6.66% | -6.75% | -2.40% | -4.76% | -15.02% |
| Total Preferred Equity | 2.61% | 1.32% | 1.34% | 1.36% | 2.08% |
| Total Minority Interest | -100.00% | -55.00% | 75.31% | -326.32% | -111.24% |
| Total Equity | 6.58% | -6.79% | -2.20% | -4.97% | -15.90% |
|
|
|||||